Supplementary Material
2-(2-Chloroacetamido)benzoic acid (3).
Triethylamine (4.06 g, 40.1 mmol) was added in the solution of 2-aminobenzoic acid (5.0 g, 36.5 mmol) in dichloromethane (90 mL) and the mixture was cooled in an ice-water bath. A solution of chloroacetyl chloride (4.5 g, 40.1 mmol) in dichloromethane (40 mL) was added dropwise and the mixture was allowed to stir at ambient temperature overnight. The solid was filtered and washed with cold water followed by 5% diethyl ether in hexane and was air dried to afford compound 3 as a white solid (7.4 g, 95% yield 
2-(Chloromethyl)-3-(2-ethoxyphenyl)quinazolin-4(3H)-one (4).
Phosphoryl chloride (6.5 g, 42.4 mmol) was added dropwise to a mixture of 3 (3.1 g, 14.5 mmol) and 2-ethoxyaniline (2.0 g, 14.5 mmol) in acetonitrile (50 mL). The mixture was heated at reflux overnight. The reaction mixture was cooled to room temperature, poured into a slurry of ice/saturated solution of Na 2 CO 3 . The resulting solid was filtered, washed with water and air dried to give 4 as a brown solid (2.5 g, 53% yield). 
3-(2-Ethoxyphenyl)-2-(piperazin-1-yl-methyl)quinazolin-4(3H)-one (5).
Piperazine (2.7 g, 32.0 mmol) was added to a mixture of 4 (2.5 g, 8.0 mmol), K 2 CO 3 (4.4 g, 32.0 mmol) and KI (1.7 g, 10.4 mmol) in acetonitrile (75 mL). The reaction mixture was heated at 85-90 0 C overnight. After cooling, it was filtered and the solid was washed with acetonitrile.
The combined organic layers were evaporated. The resulting residue was dispersed in water and extracted with ethyl acetate. The organic layers were washed with brine, dried over Na 2 SO 4 , filtered and evaporated. The crude residue was purified by column chromatography (10% methanol, 0.5% NH 4 OH in dichloromethane) to give 5 as a yellow oil (2.3 g, 79% yield 
4-(2-(4-((3-(2-Ethoxyphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)methyl)piperazin-1-yl)-2-oxoethoxy)benzaldehyde (6).
A solution of DCC (0.500 g, 2.4 mmol) in acetonitrile (4 mL) was added to a cooled mixture of acid 2 (0.360 g, 2.0 mmol), N-hydroxysuccinimide (0.280 g, 2.4 mmol) in acetonitrile (12 mL).
After stirring at room temperature for 45 min, a solution of 5 (0.800 g, 2.2 mmol) in acetonitrile (10 mL) was added, then continued stirring overnight. The solid was filtered off and the filtrate was evaporated. The resulting residue was purified by column chromatography (8% methanol in dichloromethane) to give 6 as an off-white solid (0.847 g, 80% yield 
9-(6-((4-(2-(4-((3-(2-Ethoxyphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)methyl)piperazin-1-yl)-2-oxoethoxy)benzyl)amino)hexyl)-N-(9-azabicyclo[3.3.1]nonan-3-yl)-N-(2-methoxy-5-methylphenyl)carbamate oxalate(SW V-49s).
A solution of amine SV119 (0.386 g, 0.95 mmol) in dichloromethane (4 mL) was added into a solution of 6 (0.480 g, 0.91 mmol) in dichloromethane (4 mL). The mixture was stirred for 4 h then the solvent was evaporated. The residue was dissolved in ethanol (5 mL), then NaBH 4 (0.100 g, 2.6 mmol) was added. The mixture was stirred for 6 h, then quenched with 10% HCl solution. After the solvent was evaporated, it was basified with 10% NaOH solution, extracted with dichloromethane and evaporated. The resulting residue was purified by column chromatography (10% methanol, 0.5% NH 4 OH in dichloromethane) to give the product as free amine (0.460 g, 55% yield The KP-2 pancreatic tumor line, derived from a genetically-engineered spontaneously arising model, was assessed by immunohistochemistry; dense stroma is identified by Sirius Red staining.
